| Literature DB >> 34057173 |
Alaide Chieffo1, Dariusz Dudek2, Christian Hassager3, Alain Combes4, Mario Gramegna5, Sigrun Halvorsen6, Kurt Huber7, Vijay Kunadian8, Jiri Maly9, Jacob Eifer Møller10, Federico Pappalardo11, Giuseppe Tarantini12, Guido Tavazzi13, Holger Thiele14, Christophe Vandenbriele15,16, Nicolas van Mieghem17, Pascal Vranckx18, Nikos Werner19, Susanna Price16.
Abstract
There has been a significant increase in the use of short-term percutaneous ventricular assist devices (pVADs) as acute circulatory support in cardiogenic shock and to provide haemodynamic support during interventional procedures, including high-risk percutaneous coronary interventions. Although frequently considered together, pVADs differ in their haemodynamic effects, management, indications, insertion techniques, and monitoring requirements. This consensus document summarizes the views of an expert panel by the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the Association for Acute Cardiovascular Care (ACVC) and appraises the value of short-term pVAD. It reviews the pathophysiological context and possible indications for pVAD in different clinical settings and provides guidance regarding the management of pVAD based on existing evidence and best current practice. Published on behalf of the European Society of Cardiology. All rights reserved.Entities:
Keywords: Acute coronary syndromes; ECMO; High-risk percutaneous coronary intervention; Impella; Intra-aortic balloon pump; Mechanical circulatory support
Mesh：
Year: 2021 PMID： 34057173 PMCID： PMC8245145 DOI： 10.1093/ehjacc/zuab015
Source DB: PubMed Journal: Eur Heart J Acute Cardiovasc Care ISSN： 2048-8726